Clinical Trial Update: A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 randomized study evaluating six concentrations of topical E6201 gel for psoriasis vulgaris; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• E6201 gel (E6201 gel)

Snippet

Sponsor: Eisai Limited | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2021-06-11